ARTICLE | Distillery Therapeutics
Mir690, NADK as targets in insulin resistance
February 23, 2021 11:23 PM UTC
DISEASE CATEGORY: Endocrine/metabolic
INDICATION: Diabetes; obesity...
BCIQ Company Profiles
BCIQ Target Profiles
DISEASE CATEGORY: Endocrine/metabolic
INDICATION: Diabetes; obesity...
BCIQ Company Profiles
BCIQ Target Profiles